Meningioma Clinical Trials in Boston, Massachusetts

3 studies are recruiting for meningioma in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

    The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progressive meningioma refractory to standard therapies.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Locations
    17 in total
    Run by
    Exelixis

    See if you can join NCT07428616 on ClinicalTrials.gov

  2. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

    This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) with associated progressive tumors of vestibular schwannomas (VS), non-vest…

    Stage
    Phase 2
    Ages
    12 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Locations
    6 in total
    Run by
    Scott R. Plotkin, MD, PhD

    See if you can join NCT04374305 on ClinicalTrials.gov

  3. A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

    This study will recruit participants with Grade 2 and 3 meningiomas who have failed prior therapy. Participants will receive oral doses of JZP3507. The antitumor activity and safety of JZP3507 will be evaluated.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Mass General, Boston, Massachusetts
    Locations
    5 in total
    Run by
    Jazz Pharmaceuticals

    See if you can join NCT07533942 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.